Imlifidase

Name: Imlifidase in Kidney transplantation in highly sensitized patients: Definition and etiology
Published: 2026-09-14T15:39:06-04:00

Kidney transplantation in highly sensitized patients

Manufacturer: Hansa Biopharma
Regulatory submission: BLA submitted December 2025
Launch: Anticipated in the first quarter of 2027
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy Disease description

Definition and etiology

3 evidence topics · 2 sources

Kidney failure

“If your kidney function drops below 15 percent of normal, you are said to have kidney failure.” (opens the source at this quote in a new tab)

Sensitization risk factors

“Sensitization usually occurs as a consequence of pregnancy, blood transfusions, tissue graft or previous transplantation.” (opens the source at this quote in a new tab)

HLA sensitization

“their immune system makes antibodies against one or more HLA antigens or alleles in the donor pool.” (opens the source at this quote in a new tab)